Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_4
1
17%
Ph not_applicable
4
67%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (20.0%)
N/A4 (80.0%)

Trials by Status

completed350%
not_yet_recruiting117%
terminated233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
PROCEDURE
Total Trials
6